What Researchers Did
Researchers reviewed the medical records of 23 patients with Fournier's gangrene to see if factors like hyperbaric oxygen therapy affected their length of hospital stay or survival.
What They Found
Mortality occurred in three patients (13.1%) and was strongly linked to a delay in surgical operation, with survivors undergoing surgery in 1.7 days compared to 6.8 days for those who died. Patients treated with hyperbaric oxygen therapy had significantly longer hospital stays, averaging 25 days compared to 11 days for those not treated with HBOT, without any improvement in their survival rate.
What This Means for Canadian Patients
For Canadian patients diagnosed with Fournier's gangrene, these findings highlight the critical importance of receiving prompt surgical intervention to improve their chances of survival. The study suggests that adding hyperbaric oxygen therapy may not improve survival outcomes and could lead to a longer hospital stay for patients.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small retrospective study, meaning it looked back at past data from only 23 patients, which limits the generalizability of its findings.